theory clinical_31_10
imports Main

begin

typedecl entity
typedecl event

consts
  βCatenin :: "entity ⇒ bool"
  Genes :: "entity ⇒ bool"
  CyclinD1 :: "entity ⇒ bool"
  Expression :: "entity ⇒ bool"
  Activate :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  NecessaryFor :: "entity ⇒ entity ⇒ bool"
  Mutations :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  Activity :: "entity ⇒ bool"
  Enhance :: "event ⇒ bool"
  LeadTo :: "event ⇒ event ⇒ bool"
  Promote :: "event ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Cells :: "entity ⇒ bool"
  Result :: "event ⇒ bool"
  DueTo :: "event ⇒ entity ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"

(* Explanation 1: β-catenin activates the expression of many genes, including cyclin D1, which is necessary for cell proliferation. *)
axiomatization where
  explanation_1: "∃x y z e. βCatenin x ∧ Genes y ∧ CyclinD1 z ∧ Expression y ∧ Activate e ∧ Agent e x ∧ Patient e y ∧ NecessaryFor z Proliferation ∧ Proliferation z"

(* Explanation 2: Activating mutations of CTNNB1 enhance the activity of β-catenin, leading to increased expression of genes like cyclin D1, which directly promotes cell proliferation. *)
axiomatization where
  explanation_2: "∃x y z w e1 e2. Mutations x ∧ CTNNB1 y ∧ βCatenin z ∧ Genes w ∧ CyclinD1 w ∧ Activity z ∧ Enhance e1 ∧ Agent e1 x ∧ Patient e1 z ∧ LeadTo e1 e2 ∧ Expression w ∧ Promote e2 ∧ Agent e2 w ∧ Patient e2 z ∧ Proliferation z"

(* Explanation 3: Enhanced activity of β-catenin, due to activating mutations of CTNNB1, directly results in cell proliferation. *)
axiomatization where
  explanation_3: "∃x y z e. Activity x ∧ βCatenin x ∧ Mutations y ∧ CTNNB1 y ∧ Cells z ∧ Proliferation z ∧ Result e ∧ Agent e x ∧ Patient e z ∧ DueTo e y"

(* Explanation 4: Activating mutations of CTNNB1 result in enhanced activity of β-catenin, which directly promotes the proliferation of cells via β-catenin. *)
axiomatization where
  explanation_4: "∃x y z w e1 e2. Mutations x ∧ CTNNB1 x ∧ Activity y ∧ βCatenin y ∧ Cells z ∧ Proliferation z ∧ Result e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Promote e2 ∧ Agent e2 y ∧ Patient e2 z ∧ Via e2 y"

theorem hypothesis:
  assumes asm: "Mutations x ∧ CTNNB1 y ∧ Cells z"
  (* Hypothesis: Activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
  shows "∃x y z e. Mutations x ∧ CTNNB1 y ∧ Cells z ∧ Proliferation z ∧ βCatenin y ∧ Promote e ∧ Agent e x ∧ Patient e z ∧ Via e y"
proof -
  (* From the premise, we have known information about mutations, CTNNB1, and cells. *)
  from asm have "Mutations x ∧ CTNNB1 y ∧ Cells z" <ATP>
  (* There is a logical relation Implies(F, G), which states that activating mutations of CTNNB1 result in enhanced activity of β-catenin, leading to the promotion of cell proliferation via β-catenin. *)
  (* From explanation 4, we know that activating mutations of CTNNB1 result in enhanced activity of β-catenin, which directly promotes the proliferation of cells via β-catenin. *)
  (* Therefore, we can infer the hypothesis. *)
  then have "∃e. Proliferation z ∧ βCatenin y ∧ Promote e ∧ Agent e x ∧ Patient e z ∧ Via e y" <ATP>
  then show ?thesis <ATP>
qed

end
